Effects of microplastics and tetracycline induced intestinal damage, intestinal microbiota dysbiosis, and antibiotic resistome: metagenomic analysis in young mice
Environment International · 2025-05 · 199 · 109512
DOI: 10.1016/j.envint.2025.109512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment International, 2025-05. Verfasst von Yanan Xia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microplastics, Anti-Bacterial Agents, Tetracycline. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China International Medical Foundation, National Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation.
Abstract (Originalsprache)
Microplastics (MPs) and antibiotic tetracycline (TC) are widespread in the environment and constitute emerging combined contaminants. Young individuals are particularly vulnerable to agents that disrupt intestinal health and development. However, the combined effects of MPs and TC remain poorly understood. In this study, we developed a young mouse model exposed to polystyrene MPs, either alone or in combination with TC for 8 weeks to simulate real-life dietary exposure during early life. Our findings revealed that concurrent exposure to MPs and TC caused the most severe intestinal barrier dysfunction driven by inflammatory activation and oxidative imbalance. Moreover, exposure to MPs and TC reduced the abundance of potential probiotics while promoting the growth of opportunistic pathogens. Metagenomic analysis further indicated that co-exposure to MPs and TC enhanced the abundance of bacteria carrying either antibiotic resistance genes (ARGs) or virulence factor genes (VFGs), contributing to the widespread dissemination of potentially harmful genes. Finally, a strong positive correlation was observed between microbiota dysbiosis, ARGs, and VFGs. In general, this study highlighted the hazards of MPs and antibiotics to intestinal health in young mice, which provided a new perspective into the dynamics of pathogens, ARGs, and VFGs in early-life intestinal environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
- Department of Pediatrics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Electronic address: ocean3166@yeah.net.
Förderung
- China International Medical Foundation
- National Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
Zitieren
APA
Xia, Y., Lan, Y., Xu, Y., Liu, F., Chen, X., Luo, J., Xu, H., & Liu, Y. (2025). Effects of microplastics and tetracycline induced intestinal damage, intestinal microbiota dysbiosis, and antibiotic resistome: metagenomic analysis in young mice. Environment International, 199, 109512. https://doi.org/10.1016/j.envint.2025.109512
Vancouver
Xia Y, Lan Y, Xu Y, Liu F, Chen X, Luo J, et al. Effects of microplastics and tetracycline induced intestinal damage, intestinal microbiota dysbiosis, and antibiotic resistome: metagenomic analysis in young mice. Environment International. 2025;199:109512. doi:10.1016/j.envint.2025.109512
BibTeX
@article{Xia2025,
author = {Xia, Yanan and Lan, Yuzhi and Xu, Yunping and Liu, Faqun and Chen, Xiangxiang and Luo, Jinghua and Xu, Hengyi and Liu, Yang},
title = {Effects of microplastics and tetracycline induced intestinal damage, intestinal microbiota dysbiosis, and antibiotic resistome: metagenomic analysis in young mice},
journal = {Environment International},
year = {2025},
volume = {199},
pages = {109512},
doi = {10.1016/j.envint.2025.109512}
}
EUVIMED